Compared with patients with IHCA receiving epinephrine with placebo, those receiving vasopressin, steroids, and epinephrine (VSE) exhibited significant increases in ROSC, survival to hospital discharge, favorable neurological outcomes, mean arterial pressure, renal failure–free days, coagulation failure–free days, and insulin requirement. This evidence concerns the gene INS and kidney failure.